Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Arbli. Always confirm against the full prescribing information.
100 interactions
Abatacept
The metabolism of Losartan can be increased when combined with Abatacept.
Level 1 evidence
Acebutolol
Losartan may increase the arrhythmogenic activities of Acebutolol.
Level 1 evidence
Aceclofenac
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Losartan is combined with Aceclofenac.
Level 1 evidence
Acetylsalicylic acid
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Losartan is combined with Acetylsalicylic acid.
Level 1 evidence
Acoramidis
The metabolism of Losartan can be decreased when combined with Acoramidis.
Level 2 evidence
Adagrasib
The metabolism of Losartan can be decreased when combined with Adagrasib.
Level 2 evidence
Adalimumab
The metabolism of Losartan can be increased when combined with Adalimumab.
Level 1 evidence
Adenosine
Adenosine may increase the arrhythmogenic activities of Losartan.
Level 1 evidence
Aliskiren
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Losartan.
Level 1 evidence
Alogliptin
The risk or severity of angioedema can be increased when Losartan is combined with Alogliptin.
Level 2 evidence
Alpelisib
The serum concentration of Losartan can be decreased when it is combined with Alpelisib.
Level 2 evidence
Alteplase
The risk or severity of angioedema can be increased when Alteplase is combined with Losartan.
Level 2 evidence
Enter your NPI to unlock 3 major interactions for Arbli
Arbli (Losartan Potassium) has 866 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Arbli (Losartan Potassium) has 48 major, 296 moderate, and 522 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Arbli. Always confirm against the full prescribing information.